In silico screening and evaluation of antiviral peptides as inhibitors against ORF9b protein of SARS-CoV-2-Reference-Cited by-同舟云学术

In silico screening and evaluation of antiviral peptides as inhibitors against ORF9b protein of SARS-CoV-2

Published:2024-08-06 Issue:9 Volume:14 Page:
ISSN:2190-572X
Container-title:3 Biotech
language:en
Short-container-title:3 Biotech

Author:

Sharma Gaurav,Paul Prateek,Dviwedi Ananya,Kaur Parneet,Kumar Pradeep,Gupta V. Kumar,Saha Saurav Bhaskar,Kulshrestha Saurabh^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13205-024-04032-4.pdf

Reference54 articles.

1. Armstrong K (2021) Covid-19 and the investigator pipeline. N Engl J Med 385:7–9. https://doi.org/10.1056/NEJMp2100086

2. Batista C, Shoham S, Ergonul O, Hotez P, Bottazzi ME, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow D, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Smith AW, Sow SO, Yadav P, Wourgaft NS (2021) Urgent needs to accelerate the race for COVID-19 therapeutics. E Clin Med 36:100911. https://doi.org/10.1016/j.eclinm.2021.100911

3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucl Acids Res 28(1):235–242. https://doi.org/10.1093/nar/28.1.235

4. Bolognesi DP (2006) Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids. U.S. Patent and Trademark Office. https://patents.google.com/patent/US7122190B2/en. Accessed 17 November 2022

5. Bosch BJ, Martina BEE, Zee RVD, Lepault J, Haijema BJ, Versluis C, Heck AJR, Groot RD, Osterhaus ADME, Rottier PJM (2004) Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci USA 101(22):8455–8460. https://doi.org/10.1073/pnas.0400576101